Skip to main content
Epigral Limited logo

Epigral Limited — Investor Relations & Filings

Ticker · EPIGRAL ISIN · INE071N01016 LEI · 3358008YTT28JYLL4516 BSE.NS Manufacturing
Open in API
Filings indexed 551 across all filing types
Latest filing 2025-01-20 Regulatory Filings
Country IN India
Listing BSE.NS EPIGRAL

About Epigral Limited

https://epigral.com/

Epigral Limited, formerly Meghmani Finechem Limited, operates an integrated chemical complex specializing in chlor-alkali and derivative products. The company’s core portfolio includes caustic soda, chlorine, and hydrogen, which serve as building blocks for its value-added downstream products. Key offerings include chloromethanes, hydrogen peroxide, and CPVC resin. Epigral is the first domestic producer of Epichlorohydrin (ECH), utilizing a bio-based manufacturing process. Its products are essential inputs for various applications in pharmaceuticals, textiles, water treatment, and plastics. The company focuses on expanding its specialty chemical portfolio through backward and forward integration, utilizing advanced technology to optimize production efficiency and meet the requirements of diverse global markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-20 English
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for January 27, 2025. It mentions the agenda items including approval of Un-Audited Financial Results for the third quarter and nine months ended December 31, 2024, and consideration of an interim dividend. The document is an intimation or announcement of the meeting and its agenda, not the actual financial results or dividend declaration. The length is short (1770 characters), and it serves as a notification to shareholders and exchanges. According to the classification rules, such notices about board meetings and agenda fall under Board/Management Information (MANG).
2025-01-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, for the quarter ended 31st December 2024. It is a confirmation certificate from the Registrar and Share Transfer Agent, submitted to stock exchanges. The document is short (1273 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not qualify as full reports or announcements.
2025-01-09 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them about a change in the name of the company's Registrar and Share Transfer Agent (RTA). It does not contain financial data, audit information, management changes, or any report content. It is an announcement of a corporate administrative update related to share transfer agent details. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related notifications that do not fit other specific categories.
2025-01-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (1611 characters) addressed to stock exchanges informing about a scheduled one-on-one video conference meeting with an investor (Dymon Asia Capital) on 27th December 2024. It references Regulation 30 and SEBI Listing Obligations, which govern disclosure of material events. The document states that the latest Earnings Presentation and Corporate Presentation are already available on the company's website and that no unpublished price sensitive information will be shared. There are no financial statements or detailed financial data included, nor is this a transcript or report. The document is an announcement of an investor meeting, not the meeting materials themselves. Given the short length and nature of the content, this fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about an investor meeting and does not fit other more specific categories like Investor Presentation or Earnings Release. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-12-26 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the closure of the trading window for insiders and designated persons due to the upcoming declaration of the company's un-audited financial results for the third quarter and nine months ended December 31, 2024. It references regulatory provisions related to insider trading and trading restrictions but does not contain any financial data, results, or detailed report content. The document is short (1712 characters) and serves as an announcement about trading restrictions ahead of a financial results release. Therefore, it is not a financial report itself but a regulatory announcement related to trading compliance. This fits best under Regulatory Filings (RNS).
2024-12-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.